Review each preparation on its own merits
Keep clinical evidence, regulatory status, and supplier qualification as separate questions. A promising mechanism or a product’s appearance in another clinic’s menu does not answer any of them. FDA identifies safety concerns for several peptides marketed in this area, including thymosin-alpha-1 and MOTs-C.
Avoid one storage rule for a mixed menu
Record the labeled storage conditions and expiry or beyond-use date for each approved presentation. Do not assume different preparations share refrigeration, light-protection, or handling requirements. Establish receiving and quarantine procedures with the clinical or quality lead using our cold-chain guide.
Control low-volume inventory and expiry
Review slower-moving items individually rather than rolling them into an overall purchasing budget. A volume discount has little value if stock expires before use. Compare minimum order quantities with expected consumption and confirmed usable shelf life; request those details in the quote rather than assuming them.
Make each lot traceable through the practice
Link the approved purchase, shipment records, lot-specific documents, inventory movements, and applicable clinical records within your own secure systems. Our COA guide explains how to review identity and test results without mistaking purity for clinical suitability.
